Retroperitoneal lymph node dissection for germ cell tumour

Vy Tran1, Luke Gibson1, Shomik Sengupta1,2,3

  • 1Department of Urology, Eastern Health, Box Hill, Victoria, Australia.

Insights

Retroperitoneal lymph node dissection (RPLND) aids in managing metastatic germ cell tumors by removing lymph nodes. Nerve-sparing techniques and minimally invasive approaches may improve outcomes and reduce complications like loss of ejaculation.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Urology

Background:

  • Retroperitoneal lymph node dissection (RPLND) is a critical surgical procedure for managing metastatic germ cell tumors.
  • It involves removing lymph nodes from the retroperitoneal area, the common site for testicular tumor metastasis.

Purpose of the Study:

  • To review the indications, surgical approaches, techniques, and outcomes of RPLND.
  • To assess the potential benefits of nerve-sparing and minimally invasive techniques in RPLND.

Main Methods:

  • A narrative review of existing literature was conducted.
  • The review assessed studies on RPLND indications, operative techniques, and patient outcomes.

Main Results:

  • RPLND is used for staging or treating metastases, often after chemotherapy for residual masses.
  • Significant risks include morbidity and loss of ejaculation due to hypogastric nerve damage.
  • Nerve-sparing surgery and minimally invasive approaches show potential for improved outcomes and recovery.

Conclusions:

  • RPLND is an important but complex surgery for germ cell tumors.
  • Further research is needed due to the prevalence of small retrospective studies.

Related Concept Videos